scholarly journals Mobile Stroke Unit (MSU): The Future of Acute Stroke Treatment?

2016 ◽  
Vol 3 (1) ◽  
pp. e1-e4
Author(s):  
Waldo R. Guerrero ◽  
Stroke ◽  
2019 ◽  
Vol 50 (Suppl_1) ◽  
Author(s):  
Karianne Larsen ◽  
Lars H Tveit ◽  
Henriette S Jæger ◽  
Maren R Hov ◽  
Jo Røislien ◽  
...  

2019 ◽  
Vol 112 ◽  
pp. 214-221 ◽  
Author(s):  
Adam A. Dmytriw ◽  
Yuchen Zhang ◽  
Vitor Mendes Pereira

Author(s):  
Hugh Markus ◽  
Anthony Pereira ◽  
Geoffrey Cloud

In this chapter the use of thrombolysis and the more recent application of thrombectomy in acute ischaemic stroke are covered. Organized stroke unit care has a major impact on both reducing mortality and improving outcome, and the chapter describes the evidence for this. It also covers other components of supportive acute stroke care, including the importance of instituting measures to avoid complications and to prevent early recurrent stroke.


2020 ◽  
Vol 3 (2) ◽  
pp. 116-123
Author(s):  
Mathew Cherian ◽  
Pankaj Mehta ◽  
Shriram Varadharajan ◽  
Santosh Poyyamozhi ◽  
Elango Swamiappan ◽  
...  

Background: We review our initial experience of India’s and Asia’s first mobile stroke unit (MSU) following the completion of its first year of operation. We outline the clinical care pathway integrating the MSU services using a case example taking readers along our clinical care workflow while highlighting the challenges faced in organizing and optimizing such services in India. Methods: Retrospective review of data collected for all patients from March 2018 to February 2019 transported and treated within the MSU during the first year of its operation. Recent case example is reviewed highlighting complete comprehensive acute clinical care pathway from prehospital MSU services to advanced endovascular treatment with focus on challenges faced in developing nation for stroke care. Results: The MSU was dispatched and utilized for 14 patients with clinical symptoms of acute stroke. These patients were predominantly males (64%) with median age of 59 years. Ischemic stroke was seen in 7 patients, hemorrhagic in 6, and 1 patient was classified as stroke mimic. Intravenous tissue plasminogen activator was administered to 3 patients within MSU. Most of the patients’ treatment was initiated within 2 h of symptom onset and with the median time of patient contact (rendezvous) following stroke being 55 mins. Conclusion: Retrospective review of Asia’s first MSU reveals its proof of concept in India. Although the number of patients availing treatment in MSU is low as compared to elsewhere in the world, increased public awareness with active government support including subsidizing treatment costs could accelerate development of optimal prehospital acute stroke care policy in India.


Sign in / Sign up

Export Citation Format

Share Document